Copyright Reports & Markets. All rights reserved.

Global Nuclear Medicine & Radiopharmaceuticals Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Industry Overview of Nuclear Medicine & Radiopharmaceuticals

    • 1.1 Brief Introduction of Nuclear Medicine & Radiopharmaceuticals
    • 1.2 Classification of Nuclear Medicine & Radiopharmaceuticals
    • 1.3 Applications of Nuclear Medicine & Radiopharmaceuticals
    • 1.4 Market Analysis by Countries of Nuclear Medicine & Radiopharmaceuticals
      • 1.4.1 United States Status and Prospect (2014-2024)
      • 1.4.2 Canada Status and Prospect (2014-2024)
      • 1.4.3 Germany Status and Prospect (2014-2024)
      • 1.4.4 France Status and Prospect (2014-2024)
      • 1.4.5 UK Status and Prospect (2014-2024)
      • 1.4.6 Italy Status and Prospect (2014-2024)
      • 1.4.7 Russia Status and Prospect (2014-2024)
      • 1.4.8 Spain Status and Prospect (2014-2024)
      • 1.4.9 China Status and Prospect (2014-2024)
      • 1.4.10 Japan Status and Prospect (2014-2024)
      • 1.4.11 Korea Status and Prospect (2014-2024)
      • 1.4.12 India Status and Prospect (2014-2024)
      • 1.4.13 Australia Status and Prospect (2014-2024)
      • 1.4.14 New Zealand Status and Prospect (2014-2024)
      • 1.4.15 Southeast Asia Status and Prospect (2014-2024)
      • 1.4.16 Middle East Status and Prospect (2014-2024)
      • 1.4.17 Africa Status and Prospect (2014-2024)
      • 1.4.18 Mexico East Status and Prospect (2014-2024)
      • 1.4.19 Brazil Status and Prospect (2014-2024)
      • 1.4.20 C. America Status and Prospect (2014-2024)
      • 1.4.21 Chile Status and Prospect (2014-2024)
      • 1.4.22 Peru Status and Prospect (2014-2024)
      • 1.4.23 Colombia Status and Prospect (2014-2024)

    2 Major Manufacturers Analysis of Nuclear Medicine & Radiopharmaceuticals

    • 2.1 Company 1
      • 2.1.1 Company Profile
      • 2.1.2 Product Picture and Specifications
      • 2.1.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.1.4 Contact Information
    • 2.2 Company 2
      • 2.2.1 Company Profile
      • 2.2.2 Product Picture and Specifications
      • 2.2.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.2.4 Contact Information
    • 2.3 Company 3
      • 2.3.1 Company Profile
      • 2.3.2 Product Picture and Specifications
      • 2.3.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.3.4 Contact Information
    • 2.4 Company 4
      • 2.4.1 Company Profile
      • 2.4.2 Product Picture and Specifications
      • 2.4.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.4.4 Contact Information
    • 2.5 Company 5
      • 2.5.1 Company Profile
      • 2.5.2 Product Picture and Specifications
      • 2.5.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.5.4 Contact Information
    • 2.6 Company 6
      • 2.6.1 Company Profile
      • 2.6.2 Product Picture and Specifications
      • 2.6.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.6.4 Contact Information
    • 2.7 Company 7
      • 2.7.1 Company Profile
      • 2.7.2 Product Picture and Specifications
      • 2.7.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.7.4 Contact Information
    • 2.8 Company 8
      • 2.8.1 Company Profile
      • 2.8.2 Product Picture and Specifications
      • 2.8.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.8.4 Contact Information
    • 2.9 Company 9
      • 2.9.1 Company Profile
      • 2.9.2 Product Picture and Specifications
      • 2.9.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.9.4 Contact Information
    • 2.10 Company 10
      • 2.10.1 Company Profile
      • 2.10.2 Product Picture and Specifications
      • 2.10.3 Capacity, Sales, Price, Cost, Gross and Revenue
      • 2.10.4 Contact Information

    . . .

      3 Global Price, Sales and Revenue Analysis of Nuclear Medicine & Radiopharmaceuticals by Regions, Manufacturers, Types and Applications

      • 3.1 Global Sales and Revenue of Nuclear Medicine & Radiopharmaceuticals by Regions 2014-2019
      • 3.2 Global Sales and Revenue of Nuclear Medicine & Radiopharmaceuticals by Manufacturers 2014-2019
      • 3.3 Global Sales and Revenue of Nuclear Medicine & Radiopharmaceuticals by Types 2014-2019
      • 3.4 Global Sales and Revenue of Nuclear Medicine & Radiopharmaceuticals by Applications 2014-2019
      • 3.5 Sales Price Analysis of Global Nuclear Medicine & Radiopharmaceuticals by Regions, Manufacturers, Types and Applications in 2014-2019

      4 North America Sales and Revenue Analysis of Nuclear Medicine & Radiopharmaceuticals by Countries

      • 4.1. North America Nuclear Medicine & Radiopharmaceuticals Sales and Revenue Analysis by Countries (2014-2019)
      • 4.2 United States Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 4.3 Canada Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)

      5 Europe Sales and Revenue Analysis of Nuclear Medicine & Radiopharmaceuticals by Countries

      • 5.1. Europe Nuclear Medicine & Radiopharmaceuticals Sales and Revenue Analysis by Countries (2014-2019)
      • 5.2 Germany Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 5.3 France Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 5.4 UK Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 5.5 Italy Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 5.6 Russia Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 5.7 Spain Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)

      6 Asia Pacifi Sales and Revenue Analysis of Nuclear Medicine & Radiopharmaceuticals by Countries

      • 6.1. Asia Pacifi Nuclear Medicine & Radiopharmaceuticals Sales and Revenue Analysis by Countries (2014-2019)
      • 6.2 China Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 6.3 Japan Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 6.4 Korea Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 6.5 India Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 6.6 Australia Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 6.7 New Zealand Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 6.8 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)

      7 Latin America Sales and Revenue Analysis of Nuclear Medicine & Radiopharmaceuticals by Countries

      • 7.1. Latin America Nuclear Medicine & Radiopharmaceuticals Sales and Revenue Analysis by Countries (2014-2019)
      • 7.2 Mexico Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 7.3 Brazil Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 7.4 C. America Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 7.5 Chile Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 7.6 Peru Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 7.7 Colombia Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)

      8 Middle East & Africa Sales and Revenue Analysis of Nuclear Medicine & Radiopharmaceuticals by Countries

      • 8.1. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales and Revenue Analysis by Countries (2014-2019)
      • 8.2 Middle East Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)
      • 8.3 Africa Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Growth Rate (2014-2019)

      9 Global Market Forecast of Nuclear Medicine & Radiopharmaceuticals by Regions, Countries, Manufacturers, Types and Applications

      • 9.1 Global Sales and Revenue Forecast of Nuclear Medicine & Radiopharmaceuticals by Regions 2019-2024
      • 9.2 Global Sales and Revenue Forecast of Nuclear Medicine & Radiopharmaceuticals by Manufacturers 2019-2024
      • 9.3 Global Sales and Revenue Forecast of Nuclear Medicine & Radiopharmaceuticals by Types 2019-2024
      • 9.4 Global Sales and Revenue Forecast of Nuclear Medicine & Radiopharmaceuticals by Applications 2019-2024
      • 9.5 Global Revenue Forecast of Nuclear Medicine & Radiopharmaceuticals by Countries 2019-2024
        • 9.5.1 United States Revenue Forecast (2019-2024)
        • 9.5.2 Canada Revenue Forecast (2019-2024)
        • 9.5.3 Germany Revenue Forecast (2019-2024)
        • 9.5.4 France Revenue Forecast (2019-2024)
        • 9.5.5 UK Revenue Forecast (2019-2024)
        • 9.5.6 Italy Revenue Forecast (2019-2024)
        • 9.5.7 Russia Revenue Forecast (2019-2024)
        • 9.5.8 Spain Revenue Forecast (2019-2024)
        • 9.5.9 China Revenue Forecast (2019-2024)
        • 9.5.10 Japan Revenue Forecast (2019-2024)
        • 9.5.11 Korea Revenue Forecast (2019-2024)
        • 9.5.12 India Revenue Forecast (2019-2024)
        • 9.5.13 Australia Revenue Forecast (2019-2024)
        • 9.5.14 New Zealand Revenue Forecast (2019-2024)
        • 9.5.15 Southeast Asia Revenue Forecast (2019-2024)
        • 9.5.16 Middle East Revenue Forecast (2019-2024)
        • 9.5.17 Africa Revenue Forecast (2019-2024)
        • 9.5.18 Mexico East Revenue Forecast (2019-2024)
        • 9.5.19 Brazil Revenue Forecast (2019-2024)
        • 9.5.20 C. America Revenue Forecast (2019-2024)
        • 9.5.21 Chile Revenue Forecast (2019-2024)
        • 9.5.22 Peru Revenue Forecast (2019-2024)
        • 9.5.23 Colombia Revenue Forecast (2019-2024)

      10 Industry Chain Analysis of Nuclear Medicine & Radiopharmaceuticals

      • 10.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Nuclear Medicine & Radiopharmaceuticals
        • 10.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Nuclear Medicine & Radiopharmaceuticals
        • 10.1.2 Major Equipment Suppliers with Contact Information Analysis of Nuclear Medicine & Radiopharmaceuticals
      • 10.2 Downstream Major Consumers Analysis of Nuclear Medicine & Radiopharmaceuticals
      • 10.3 Major Suppliers of Nuclear Medicine & Radiopharmaceuticals with Contact Information
      • 10.4 Supply Chain Relationship Analysis of Nuclear Medicine & Radiopharmaceuticals

      11 New Project Investment Feasibility Analysis of Nuclear Medicine & Radiopharmaceuticals

      • 11.1 New Project SWOT Analysis of Nuclear Medicine & Radiopharmaceuticals
      • 11.2 New Project Investment Feasibility Analysis of Nuclear Medicine & Radiopharmaceuticals
        • 11.2.1 Project Name
        • 11.2.2 Investment Budget
        • 11.2.3 Project Product Solutions
        • 11.2.4 Project Schedule

      12 Conclusion of the Global Nuclear Medicine & Radiopharmaceuticals Industry Market Research 2019

        13 Appendix

        • 13.1 Research Methodology
          • 13.1.1 Methodology/Research Approach
          • 13.1.2 Data Source
        • 13.2 Author Details

        The Nuclear Medicine & Radiopharmaceuticals market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Nuclear Medicine & Radiopharmaceuticals.
        Global Nuclear Medicine & Radiopharmaceuticals industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain, market size (sales, revenue, and growth rate), gross margin, major manufacturers, development trends and forecast.

        Key players in global Nuclear Medicine & Radiopharmaceuticals market include:
        Bracco Imaging
        Bayer
        Mallinckrodt
        Nordion
        Triad Isotopes
        Lantheus
        IBA Group
        GE Healthcare
        China Isotope & Radiation
        Jubilant Pharma
        Eli Lilly
        Advanced Accelerator Applications
        SIEMENS
        Dongcheng
        Navidea

        Market segmentation, by product types:
        Diagnostic Radioisotopes
        Therapeutic Radioisotopes

        Market segmentation, by applications:
        Oncology
        Cardiology
        Other

        Market segmentation, by regions:
        North America (United States, Canada)
        Europe (Germany, France, UK, Italy, Russia, Spain)
        Asia Pacific (China, Japan, Korea, India, Australia, New Zealand)
        Middle East & Africa (Middle East, Africa)
        Latin America (Mexico, Brazil, C. America, Chile, Peru, Colombia)

        The report can answer the following questions:
        1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Nuclear Medicine & Radiopharmaceuticals industry.
        2. Global major manufacturers’ operating situation (sales, revenue, growth rate and gross margin) of Nuclear Medicine & Radiopharmaceuticals industry.
        3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Nuclear Medicine & Radiopharmaceuticals industry.
        4. Different types and applications of Nuclear Medicine & Radiopharmaceuticals industry, market share of each type and application by revenue.
        5. Global market size (sales, revenue) forecast by regions and countries from 2019 to2024 of Nuclear Medicine & Radiopharmaceuticals industry.
        6. Upstream raw materials and manufacturing equipment, industry chain analysis of Nuclear Medicine & Radiopharmaceuticals industry.
        7. SWOT analysis of Nuclear Medicine & Radiopharmaceuticals industry.
        8. New Project Investment Feasibility Analysis of Nuclear Medicine & Radiopharmaceuticals industry.
        Buy now